Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Research Communications in Molecular Pathology and Pharmacology
Research Communications in Molecular Pathology and Pharmacology is not currently indexed in Scopus. Published by PJD Publications Ltd.
Checked against the index lists dated .
ISSN 1078-0297Verify ISSN ↗
Publisher: PJD Publications Ltd
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Research Communications in Molecular Pathology and Pharmacology indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2009 (also 1994–2007)).
What is the impact factor of Research Communications in Molecular Pathology and Pharmacology?
Research Communications in Molecular Pathology and Pharmacology has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Research Communications in Molecular Pathology and Pharmacology and what is its ISSN?
Research Communications in Molecular Pathology and Pharmacology is published by PJD Publications Ltd. Its ISSN is 1078-0297.
Is Research Communications in Molecular Pathology and Pharmacology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Research Communications in Molecular Pathology and Pharmacology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Research Communications in Molecular Pathology and Pharmacology for 15 years, between 1994 and 2009, with 1 year in that span missing. Coverage ended in 2009, 17 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 11 works and 26 citations for the title. OpenAlex attributes papers to this title as late as 2022, 13 years after Scopus coverage ended in 2009. That may reflect a changed ISSN or merged records rather than continued publishing, so confirm the journal's current status directly before submitting.
How well cited is Research Communications in Molecular Pathology and Pharmacology? — open metrics via OpenAlex
Research Communications in Molecular Pathology and Pharmacology has an h-index of 4 and a 2-year mean of 0 citations per paper (OpenAlex).
Research Communications in Molecular Pathology and Pharmacology published 9 papers in 1995. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Research Communications in Molecular Pathology and Pharmacology? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2009. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2009
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from PJD Publications Ltd
PJD Publications Ltd has 8 other titles in our data; 1 is currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.